Please assess the completion status of the following clinical trial:

Trial Title: High (100mg) Versus Standard (60mg) Loading Dose of Prasugrel in Patients With ST-elevation Myocardial Infarction (STEMI), Undergoing Primary Percutaneous Coronary Intervention (PCI)

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* ST elevation myocardial infarction~* Pain onset \<12 hours~* Age \>18 and \<75 years~* Written informed consent~Exclusion Criteria:~* history of stroke/transient ischemic attack~* oral anticoagulation~* hemodynamic instability~* platelet count \<100000/μL~* hematocrit \<30%~* creatinine clearance \<30 ml/min~* severe hepatic dysfunction~* active bleeding~* weight \<60 Kg~* periprocedural IIb/IIIa inhibitor administration

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 74 Years
- Healthy Volunteers: f

Study Arms:
- Prasugrel 100mg loading dose (Type: EXPERIMENTAL): Prasugrel 100mg loading dose
- Prasugrel 60mg loading dose (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).